Peptide 234CM TFA is a peptide containing isoleucine at position 3, corresponding to the sequence of a point mutation in p53 codon 234. Peptide 234CM TFA induces potent cytotoxic T cell (CTL) and antitumor immune responses against mutant p53 [1].
References:
[1]. Gabrilovich, et al. "Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function." Clinical cancer research 5.10 (1999): 2963-2970.
References:
[1]. Gabrilovich, et al. "Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function." Clinical cancer research 5.10 (1999): 2963-2970.